Peripheral Vascular Devices and Accessories Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Market Overview

The peripheral vascular devices and accessories market is expected to witness a CAGR of 7.1% during the study period, 2022-2027.

In the past two years, countries have faced a huge threat of COVID-19. As per the World Health Organization (WHO), coronavirus disease is an infectious disease, and most people infected with the COVID-19 virus experience mild to moderate respiratory illness. The COVID-19 pandemic led to disruption in not only the research and development activities of other therapies than COVID-19 but also impacted the treatment procedures and supply chain of medical devices in the country. The peripheral vascular devices and accessories market growth has been positively impacted by COVID-19 owing to the increasing need for remote monitoring in cardiac patients and the effects of COVID-19 in the patients.

The increasing burden of cardiac failures due to COVID-19 is also boosting the growth of peripheral vascular devices and accessories. For instance, the Indian Heart Journal article titled ‘Cardiological society of India position statement on COVID-19 and heart failure’ published in May 2020 reported that patients with COVID-19 present with predominantly respiratory symptoms like cough and dyspnoea, which can lead to worsened heart failure or acute decompensated heart failure (ADHF). However, with the introduction of vaccines and the upliftment of lockdown in various countries across the globe, there might be an increase in the number of patients undergoing cardiac procedures, thereby expanding the scope of market growth in the near future.

The factors propelling the studied market growth are the rising demand for minimally invasive procedures and an increase in the prevalence of peripheral artery diseases. In addition, new product launches and strategic initiatives taken by the key market players will further drive the market growth.

Peripheral arterial disease (PAD), also known as Peripheral vascular disease (PVD), is found to be caused by a narrowing or blocking of the blood vessels due to a build-up of plaque. This condition leads to tissue death, heart stroke, aneurysms, or kidney diseases if left untreated. Therefore, this requires early treatment, thereby driving the market as per the study article “Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association,” published in July 2021, peripheral artery disease (PAD) affects nearly 230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes such as coronary heart disease, stroke, and others. Therefore, the high burden of PAD globally and the risk factors associated with it are expected to propel the demand for peripheral vascular devices and accessories and, therefore, the market.

Additionally, strategic initiatives such as product launches, mergers and acquisitions, and others will also lead to lucrative growth of the market. For instance, in November 2021, Otsuka Medical Devices Co., Ltd. Launched BioMimics 3D Vascular Stent System for patients with peripheral vascular disease in Japan.

Furthermore, in December 2021, Royal Philips signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. This acquisition will help Philips to further expand its product portfolio and geographical reach, thereby strategically diversifying the company. Such strategic initiatives will positively contribute to market growth.

Therefore, owing to the aforementioned factors, the studied market is expected to grow significantly during the study period. However, strict regulations related to product approvals related to peripheral vascular are expected to hinder the market growth during the study period.

Scope of the Report

As per the scope of the report, vascular devices can be referred to as medical devices utilized in the case of catheterization post cardiovascular surgery for the closure and achieving hemostasis in the artery. The peripheral vascular devices and accessories market is segmented by Product (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty (PTA) Balloons, Catheters, Atherectomy Devices, Peripheral Accessories, and Others), Guidewire Coating Type (Hydrophobic Coating Wires and Hydrophilic Coating Wires) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Atherectomy Devices Segment is Expected to Account for the Largest Market Share During the Forecast Period

Atherectomy has been used effectively in the treatment of both coronary and peripheral arterial disease. Atherectomy devices are designed differently to either cut, shave, sand, or vaporize these plaques and have different indications. The SilverHawk and TurboHawk plaque excision systems are the two United States FDA-approved directional atherectomy devices that are in use.

The rise in the incidence of peripheral artery disease worldwide, especially among the aging population, has driven the demand for atherectomy procedures. Since several medical facilities are using atherectomy procedures to treat peripheral artery disease, an increase in demand and sales for atherectomy devices is expected over the forecast period.

Additionally, the rise in product launches and research and development studies in the studied segment will also contribute to the market growth. For instance, in November 2021, Royal Philips announced the North American debut of new peripheral and coronary artery applications, including the Nexcimer laser system for peripheral and coronary atherectomy and lead extraction procedures.

In August 2021, the Food and Drug Administration announced the successful 510(k) application of Medtronic’s TurboHawk Plus Directional Atherectomy System, an updated version of its older and largely phased out atherectomy device to support market growth outside of the United States. This will help the company to expand its footprint, thus driving the market.

Furthermore, increasing research and development studies proving the efficacies of atherectomy devices will also boost the market growth. For instance, a study is expected to be initiated in April 2022 by Icahn School of Medicine at Mount Sinai to evaluate if rotational atherectomy with the addition of a cutting balloon will result in increased blood vessel lumen, more optimal stent expansion, and decreased cardiac problems compared to current standard treatment. This study is expected to be completed by December 2023. Such studies will increase the adaptability of the existing devices, thus driving the market.

Thus, due to the above-mentioned factors, the studied segment is expected to contribute to the significant growth of the market.

To understand key trends, Download Sample Report